AI-driven software company outlines its idiosnycratic beliefs, arguing for greater social tolerance and understanding while looking ahead to future warfare as a grim inevitabilty
AI-driven software company outlines its idiosnycratic beliefs, arguing for greater social tolerance and understanding while looking ahead to future warfare as a grim inevitabilty
The Pure Electric Truck Chassis Market is witnessing substantial growth, expected to reach USD 17.98 billion by 2032 with a CAGR of 11.36%. This growth is driven by advances in technology integration within electric truck chassis, including battery integration, e-axles, and software-defined controls that enhance performance and reduce total ownership costs. The development of "skateboard" and semi...
The Pure Electric Truck Chassis Market is witnessing substantial growth, expected to reach USD 17.98 billion by 2032 with a CAGR of 11.36%. This growth is driven by advances in technology integration within electric truck chassis, including battery integration, e-axles, and software-defined controls that enhance performance and reduce total ownership costs. The development of "skateboard" and semi-integrated chassis designs, along with modular platforms, allows for improved stability,...
Prelude Therapeutics ( PRLD ) has priced a public offering of more than 18M shares of its voting common stock at $4.44 each, along with pre-funded warrants for up to 2.25M additional shares at $4.4399 each. Gross proceeds are estimated to be approximately $90M. The offering is expected to close on or about April 21, 2026, subject to the satisfaction of customary closing conditions. The company int...
Prelude Therapeutics ( PRLD ) has priced a public offering of more than 18M shares of its voting common stock at $4.44 each, along with pre-funded warrants for up to 2.25M additional shares at $4.4399 each. Gross proceeds are estimated to be approximately $90M. The offering is expected to close on or about April 21, 2026, subject to the satisfaction of customary closing conditions. The company intends to use the net proceeds from the offering primarily for general corporate purposes, which may include funding research, preclinical and clinical development of its product candidates, increasing its working capital, and capital expenditures. The offering was led by new investor RA Capital Management with participation from Soleus Capital, as well as other new and existing healthcare dedicated investors. Goldman Sachs & Co. LLC, Evercore ISI and Citizens Capital Markets are acting as the joint book-running managers for the offering. PRLD shares +10.36% premarket. Source: Press Release More on Prelude Therapeutics Prelude climbs as FDA clears study for Incyte-partnered cancer candidate Seeking Alpha’s Quant Rating on Prelude Therapeutics Historical earnings data for Prelude Therapeutics Financial information for Prelude Therapeutics
(RTTNews) - USA Rare Earth Inc. (USAR) on Monday said it has agreed to acquire Serra Verde Group, owner of the Pela Ema rare earth mine and processing plant in Brazil, in a deal valued at about $2.8 billion.
(RTTNews) - USA Rare Earth Inc. (USAR) on Monday said it has agreed to acquire Serra Verde Group, owner of the Pela Ema rare earth mine and processing plant in Brazil, in a deal valued at about $2.8 billion.
Mohamad Faizal Bin Ramli/iStock via Getty Images Last summer, I believed that AMETEK, Inc. ( AME ) was continuing with M&A to complement modest organic growth. The high-quality and niche industrial player announced the acquisition of FARO Technologies, which is a much larger and somewhat unusual deal for Ametek. Ever since, shares have risen by a third, vastly outperforming the wider market, as a ...
Mohamad Faizal Bin Ramli/iStock via Getty Images Last summer, I believed that AMETEK, Inc. ( AME ) was continuing with M&A to complement modest organic growth. The high-quality and niche industrial player announced the acquisition of FARO Technologies, which is a much larger and somewhat unusual deal for Ametek. Ever since, shares have risen by a third, vastly outperforming the wider market, as a premium player is awarded more premium valuations here. Trading at a 30 times earnings multiple, or 3% and change earnings yield, does not compete with risk-free rates. However, the long-term track record of compounded earnings growth is what counts, making shares not necessarily overextended, although valued at too much of a premium to see imminent appeal. Other interesting IPOs are discussed more extensively at Value In Corporate Events . Powering On Recently, investors in Ametek have seen quite some good news. In February, Ametek announced a 10% increase in the quarterly dividend, now paid at $0.34 per share, for an annual payout of $1.36 per share. This hike followed the announcement of a bolt-on deal of LKC in February, used for effective diagnosis and management of ophthalmic conditions, yet unfortunately, no financial details have been announced. Reported sales rose by nearly 7% to $7.40 billion, as fourth-quarter sales rose by 13% to $2.0 billion, as the growth acceleration was driven by the purchase of Faro. Electronic Instruments sales rose by nearly 6% to $4.92 billion, with Electromechanical sales up nearly 9% to $2.48 billion. The company grew operating margins by similar percentages, with net earnings up just over 7% to $1.48 billion. Such earnings growth and minimal share buybacks made GAAP earnings rise some forty-seven cents to $6.42 per share. Adjusted earnings rose by sixty cents to $7.43 per share, with the majority of the reconciliation driven by amortization charges, as these numbers look quite fair. Net debt is reported at $1.82 billion, trailing adju...
Hong Kong authorities have developed an artificial intelligence (AI)-driven flood forecasting and alert system capable of three-dimensional simulations, aimed at enabling more timely pre-emptive measures and emergency responses to flooding. The technology is the latest addition to the existing territory-wide flood risk visualisation system, which was deployed during Super Typhoon Ragasa last year....
Hong Kong authorities have developed an artificial intelligence (AI)-driven flood forecasting and alert system capable of three-dimensional simulations, aimed at enabling more timely pre-emptive measures and emergency responses to flooding. The technology is the latest addition to the existing territory-wide flood risk visualisation system, which was deployed during Super Typhoon Ragasa last year. “This is to foster Hong Kong as a future-facing and climate-resilient city,” Ringo Mok Wing-cheong,...
Growth investor Cathie Wood was surprisingly quiet last week, as the market raced to new highs. She lightened her stake on a pair of positions across her Ark Invest ETFs on Monday. She didn't make any trades on Tuesday or Wednesday. She pared back on a single holding on Thursday. It wasn't until Friday that Wood actually bought something, and Netflix (NASDAQ: NFLX) was one of just two existing pos...
Growth investor Cathie Wood was surprisingly quiet last week, as the market raced to new highs. She lightened her stake on a pair of positions across her Ark Invest ETFs on Monday. She didn't make any trades on Tuesday or Wednesday. She pared back on a single holding on Thursday. It wasn't until Friday that Wood actually bought something, and Netflix (NASDAQ: NFLX) was one of just two existing positions that she added to on the final trading day of last week. With Netflix shares plummeting nearly 10% on an otherwise buoyant trading day, Friday's price action stands out. Many aggressive growth investors prefer to buy stocks on the way up, but Wood doesn't usually behave like a momentum investor. Ark Invest often adds to positions on down days, even though the other stock she bought on Friday was a biotech soaring nearly 30% by the closing bell. Is Wood's contrarian stance on Netflix the right call? Let's take a look at some of the reasons why she could be wrong. I'll follow up with some reasons why investing in Netflix might be a smart thing to do. Continue reading